Sleep Number Corporation reported third quarter 2025 results with net sales of $343.0 million, a decrease of 19.6% year-over-year, primarily due to lower volume and a reduced store count. The company recorded a net loss of $40.0 million, or $1.73 per diluted share, a decline of $37.0 million from the prior year. Adjusted EBITDA was $13.0 million, down 52.0%, with an adjusted EBITDA margin of 3.9%, a decrease of 260 basis points. Net cash used in year-to-date operating activities was $5.0 million, while free cash flow was a use of $17.0 million. The company's leverage ratio was 5.0x EBITDAR, below the amended covenant maximum of 5.25x. Sleep Number successfully amended and extended its bank agreement through 2027 and achieved fixed cost reductions in 2025. The company plans to invest in growth in 2026 and is making strategic shifts in product, brand positioning, and distribution to drive consumer demand.